the financial times is reporting that the country s biggest bank, ubs, has offered to buy credit suisse for up to one billion dollars, although bloomberg reports that credit suisse sees that as vastly undervaluing the bank. the swiss banking giant had been caught up in the market uncertainty triggered by the collapse, nine days ago, of america s silicon valley bank. it had been offered an emergency credit facility of more than 50 billion dollars by switzerland s central bank but that had not prevented a sharp fall in its share price. more now on one of our main stories this hour a potential takeover of the struggling credit suisse bank by another swiss based bank, ubs. let s get the latest now from our correspondent in switzerland imogen foulkes. what is the latest on these stories to try and shore up we hearing a lot of things but i can tell you the crisis talks taking just on the road from me in berne financial authority of the banks, people are being very tight lip
thanks forjoining us on bbc news. uk inflation has hit the bank of england s target of 2% for the first time in almost three years. the figure which tells us the rate at which prices are rising hit the target in may, coming down from 2.3% in april. our chief economics correspondent dharshini david reports. gary in sussex used to have seven butchers shops. he now has four. forced to make cuts as he s been caught between soaring costs over the last few years and customers with lean budgets looking for value. but things are easing. the price is probably 10 15% more than they were at the beginning of covid, but the actual price of the product is pretty much stationary now. well, we hope it s stationary. it would be nice if it would come down, but i can t see that, not in the foreseeable future anyway. it s global food and energy costs, which triggered the rise in inflation to ii% in 2022, which have also helped it fall to the 2% target, along with the rate rises over the last
takes place. thank you very much forjoining me. welcome to our viewers on pbs in america and around the globe. let s start with the astrazeneca vaccine. the european medicines agency has been examining its safety after more than a dozen eu members suspended it this week over health concerns. and today, we heard its verdict. the committee has come to a clear scientific conclusion. this is a safe and effective vaccine. its benefits in protecting people from covid i9 with the associated risks of death and hospitalisation outweigh the possible risks. the committee also concluded that the vaccine is not associated with an increase in the overall risk of thromboembolic events or blood clots. that press conference took place in amsterdam, and our correspondent jean mackenzie was there. what they ve been saying all along stands, that they think this is a vaccine in which the benefits massively outweigh the risks. it was striking, they pointed out there how many people have died in th